Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr;21(4):218-231.

Raising Expectations in IBS-C Management

Kyle Staller  1
Affiliations

Raising Expectations in IBS-C Management

Kyle Staller. Gastroenterol Hepatol (N Y). 2025 Apr.
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Making a definitive diagnosis of IBS-C. aCriteria met for the previous 3 months with onset of symptoms at least 6 months before the diagnosis. BSFS, Bristol Stool Form Scale; d, day; IBD, inflammatory bowel disease; IBS-C, irritable bowel syndrome with constipation; wk, week. Adapted from: Spiegel B. Gastroenterol Hepatol (N Y). 2024;20(9)(suppl 7):1-12.
Figure 2.
Figure 2.
Conceptual framework to explain functional bowel disorders. FC, functional constipation; FDr, functional diarrhea; IBS-C, irritable bowel syndrome with constipation; IBS-D, irritable bowel syndrome with diarrhea; IBS-M, irritable bowel syndrome with mixed bowel habits. Adapted from: Lacy et al. Gastroenterology. 2016;150(6):1393-1407.
Figure 3.
Figure 3.
Currently available FDA-approved agents with indications for the treatment of IBS-C. CIC-2, type 2 chloride channel; FDA, US Food and Drug Administration; GC-C, guanylate cyclase-C; IBS-C, irritable bowel syndrome with constipation; NHE3, sodium/hydrogen exchanger isoform 3. Adapted from: Brenner DM. Gastroenterol Hepatol (N Y). 2023;19(12)(suppl 6):749-756.
Figure 4.
Figure 4.
Educate your patients with IBS-C: what your patients should know. IBS-C, irritable bowel syndrome with constipation; MOA, mechanism of action; QoL, quality of life.
Figure 5.
Figure 5.
Raising expectations in IBS-C management: physician’s approach to a treatment algorithm. FDA, US Food and Drug Administration; IBS-C, irritable bowel syndrome with constipation; MOA, mechanism of action; QoL, quality of life.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Lacy BE, Patel NK. Rome criteria and a diagnostic approach to irritable bowel syndrome. J Clin Med. 2017;6(11):99. - PMC - PubMed
    1. Drossman DA, Tack J. Rome Foundation clinical diagnostic criteria for disorders of gut-brain interaction. Gastroenterology. 2022;162(3):675–679. - PubMed
    1. Black CJ, Ford AC. Assessing the impact of changes to the Rome IV criteria for clinical practice in irritable bowel syndrome. Gastroenterology. 2022;162(6):1752–1754.e1. - PubMed
    1. Lacy BE, Pimentel M, Brenner DM et al. ACG Clinical Guideline: management of irritable bowel syndrome. Am J Gastroenterol. 2021;116(1):17–44. - PubMed
    1. Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol. 1997;32(9):920–924. - PubMed

LinkOut - more resources